Day: December 9, 2025

New solution suite and site enhance sports advertising – across screens and seasons – with data, creative and premium supply NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — Nexxen, a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced the launch of Nexxen Sports, a new suite of solutions that combines premium, live sports content with data-driven audience insights, targeting and dynamic creative to connect brands with highly engaged sports fans across devices. According to Nexxen’s Inside Live Sports research, 48% of Americans watch live sports, with 85% of them tuning in weekly or more. Built on Nexxen’s unified, data-led platform, including a demand-side platform (“DSP”) and supply-side platform (“SSP”), Nexxen Sports enables advertisers to reach and engage these viewers...

PHILADELPHIA, Dec. 09, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced the appointments of Han Lee, Ph.D., M.B.A., and Martin Murphy, Ph.D., to its Board of Directors. As part of their appointments, Dr. Lee will serve as a member of the Audit and the Compensation Committees and Dr. Murphy will serve as a member of the Compensation and the Nominating and Corporate Governance Committees. “We are pleased to welcome Dr. Lee and Dr. Murphy to our Board at an important time for Century as we execute with discipline and focus to bring our most differentiated iPSC-derived cell therapy programs, including CNTY-813 as a potentially curative, off-the-shelf investigational...

Company Finalizes GlycoCheck® License, Advances DocSun AI Acquisition and SDK Partnerships, and Engages Investment Bank for Planned 2026 Initiatives CHATTANOOGA, Tenn., Dec. 09, 2025 (GLOBE NEWSWIRE) — BioRegenx, Inc. (“BioRegenx” or the “Company”) (OTC: BRGX), a health-technology company pioneering non-invasive diagnostic and predictive analytics solutions for microvascular and metabolic health, today announced a series of significant corporate, technological, and strategic milestones. HighlightsEngaged a new PCAOB-registered independent auditor following industry-wide SEC actions affecting prior firms. Finalized intellectual property license for the clinically validated GlycoCheck® vascular diagnostic platform. Fully integrated DocSun Biomedical Holdings, Inc., adding AI-driven non-contact vital-sign detection and SDK licensing...

VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) —  HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that James Baker will join the Company’s Technical Advisory Board (TAB), bringing more than three decades of experience in advanced materials, aerospace, defence, and graphene commercialisation. For the last 12 years, Mr. Baker led business activities related to graphene and 2D materials at the University of Manchester, including serving as Chief Executive Officer of the globally recognized Graphene Engineering Innovation Centre (GEIC). Prior to his work in graphene, he spent 25 years in the aerospace and defence industry in senior roles focused on technology development and industrial innovation at BAE Systems and Pilkington Optronics. Mr. Baker has announced that he...

All figures are in US dollars unless otherwise stated. LEWISVILLE, Ark., Dec. 09, 2025 (GLOBE NEWSWIRE) — Smackover Lithium, a Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI) and Equinor, is providing an update with respect to the project financing being pursued for the South West Arkansas Project (“SWA Project” or the “Project”). Smackover Lithium has received expressions of interest from three major Export Credit Agencies (“ECAs”), including among them Export-Import Bank of the United States (EXIM) and Export Finance Norway (Eksfin), for over $1 billion in senior secured project debt (the “ECA Financing”) to fund the construction of Phase 1 of the SWA Project.   Smackover Lithium is currently seeking a senior secured, limited recourse debt financing package of...

Enhanced capabilities deliver superior device recognition, advanced anomaly detection and adaptive machine learning, helping businesses stay ahead of evolving fraud threats CHICAGO, Dec. 09, 2025 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) has introduced a major advancement to its Device Risk solution, delivering next-level capabilities that redefine how businesses combat fraud. This breakthrough empowers organizations to identify risky devices with unprecedented precision, uncover hidden anomalies, and dynamically optimize fraud strategies in real time—helping them stay ahead of increasingly sophisticated threats. The enhancements come as fraud continues to escalate at an alarming pace, costing businesses an average of 7.7% of annual revenue—totaling $534 billion. As fraudsters deploy increasingly sophisticated tactics, businesses...

New features use personalization to help fans discover the best deals on live events CHICAGO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today unveiled an upgrade to its mobile app, elevating the platform to a more interactive event discovery hub. Built with today’s on-the-go fan in mind, the updated Vivid Seats app introduces a set of intuitive features designed to make it easier than ever to explore events, uncover local experiences, and score great ticket deals, all in one accessible experience. Whether you’re planning a weekend concert crawl or a last-minute road trip to see your favorite team, the updated Vivid Seats’ app puts...